94 related articles for article (PubMed ID: 3904416)
1. In vitro generation of procoagulant activity by leukemic promyelocytes in response to cytotoxic drugs.
Fibach E; Treves A; Korenberg A; Rachmilewitz EA
Am J Hematol; 1985 Nov; 20(3):257-65. PubMed ID: 3904416
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor expression in human leukemic cells.
Hair GA; Padula S; Zeff R; Schmeizl M; Contrino J; Kreutzer DL; de Moerloose P; Boyd AW; Stanley I; Burgess AW; Rickles FR
Leuk Res; 1996 Jan; 20(1):1-11. PubMed ID: 8632672
[TBL] [Abstract][Full Text] [Related]
3. Procoagulant cellular activity and disseminated intravascular coagulation in acute non-lymphoid leukaemia.
Guarini A; Gugliotta L; Timoncini C; Chetti L; Catani L; Russo D; Tura S
Scand J Haematol; 1985 Feb; 34(2):152-6. PubMed ID: 3975570
[TBL] [Abstract][Full Text] [Related]
4. An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF.
Langer F; Amirkhosravi A; Loges S; Meyer T; Eifrig B; Hossfeld DK; Fiedler W; Francis JL
Thromb Haemost; 2004 Nov; 92(5):1136-46. PubMed ID: 15543344
[TBL] [Abstract][Full Text] [Related]
5. Coagulant and fibrinolytic activities in the leukemic cell lysates.
Wada H; Nagano T; Tomeoku M; Kuto M; Karitani Y; Deguchi K; Shirakawa S
Thromb Res; 1983 May; 30(4):315-22. PubMed ID: 6351339
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
[TBL] [Abstract][Full Text] [Related]
7. [Activity of procoagulant and fibrinolysis in homogenate of leukemic cells].
Wada H; Tanigawa M; Suzuki H; Takagi M; Mori Y; Ohno T; Kita K; Kobayashi T; Deguchi K; Shirakawa S
Rinsho Ketsueki; 1989 Oct; 30(10):1783-7. PubMed ID: 2593244
[TBL] [Abstract][Full Text] [Related]
8. Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state.
Gheldof D; Mullier F; Bailly N; Devalet B; Dogné JM; Chatelain B; Chatelain C
Thromb Res; 2014 Mar; 133(3):433-9. PubMed ID: 24290525
[TBL] [Abstract][Full Text] [Related]
9. The expression of tissue factor antigen and activity on the surface of leukemic cells.
Tanaka M; Yamanishi H
Leuk Res; 1993 Feb; 17(2):103-11. PubMed ID: 8429686
[TBL] [Abstract][Full Text] [Related]
10. [Role of Microparticles Derived from Acute Promyelocytic Leukemia Cells in Coagulopathy].
Zhang YM; Chen B; Wu LY; Hou JX; Fu JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):693-698. PubMed ID: 28641620
[TBL] [Abstract][Full Text] [Related]
11. Induction of cytotoxic effector activity in the HL-60 promyelocytic cell line by incubation with phorbol myristate acetate: a model system of human spontaneous monocyte-mediated cytotoxicity.
Hall RE; Muchmore AV; Decker JM; Blaese RM
Cell Immunol; 1983 Feb; 76(1):58-68. PubMed ID: 6572566
[TBL] [Abstract][Full Text] [Related]
12. Expression of procoagulant activity in a human monocyte-like cell line.
Ewan VA; Edwards RL; Rickles FR
J Lab Clin Med; 1983 Mar; 101(3):401-10. PubMed ID: 6338139
[TBL] [Abstract][Full Text] [Related]
13. Cell-based evaluation of changes in coagulation activity induced by antineoplastic drugs for the treatment of acute myeloid leukemia.
Tsunaka M; Shinki H; Koyama T
PLoS One; 2017; 12(4):e0175765. PubMed ID: 28406995
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor released from leukemic cells.
Kubota T; Andoh K; Sadakata H; Tanaka H; Kobayashi N
Thromb Haemost; 1991 Jan; 65(1):59-63. PubMed ID: 2024239
[TBL] [Abstract][Full Text] [Related]
15. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
[TBL] [Abstract][Full Text] [Related]
16. [Effects of realgar on tissue factor expression of NB4 and MR2 cells].
Zhao XA; Liu SX
Zhongguo Zhong Yao Za Zhi; 2003 Jun; 28(6):553-6. PubMed ID: 15015339
[TBL] [Abstract][Full Text] [Related]
17. [Effects of all-trans retinoic acid and arsenic trioxide on tissue factor expression of acute promyelocytic leukemia cells].
Guo W; Wang H; Zhao W
Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):327-31. PubMed ID: 11798779
[TBL] [Abstract][Full Text] [Related]
18. Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.
Gheldof D; Haguet H; Dogné JM; Bouvy C; Graux C; George F; Sonet A; Chatelain C; Chatelain B; Mullier F
J Thromb Thrombolysis; 2017 Feb; 43(2):224-232. PubMed ID: 28074413
[TBL] [Abstract][Full Text] [Related]
19. New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia.
Tallman MS; Hakimian D; Kwaan HC; Rickles FR
Leuk Lymphoma; 1993 Sep; 11(1-2):27-36. PubMed ID: 8220153
[TBL] [Abstract][Full Text] [Related]
20. White cell-associated procoagulant activity induced by ABO incompatibility.
Davenport RD; Polak TJ; Kunkel SL
Transfusion; 1994; 34(11):943-9. PubMed ID: 7974702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
